Clinical Trials in Dallas

Showing 9981-10000 of 17,468 trials

Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients

NCT00795418

This study will evaluate the safety and tolerability of repeated subcutaneous injections of CAD106 in patients with mid Alzheimer's disease

Alzheimer's Disease

Novartis31 participantsStarted Oct 2008

Costa Mesa, California, United States • Boulder, Colorado, United States • Hollywood, Florida, United States +7 more locations

No Longer Available< 1 mile

PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation

NCT02475798

The purpose of this extended study is to collect confirmatory safety and effectiveness data on the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the commercially available Atrium iCAST™ covered stent in the treatment of aortoiliac and iliac aneurysms.

Aortoiliac AneurysmsIliac Aneurysms

Cook Research Incorporated

Phoenix, Arizona, United States • Palo Alto, California, United States • Stanford, California, United States +23 more locations

Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients

PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation

Find Trials by Condition in Dallas

A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications

Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol

Evaluation of Biomarkers of Traumatic Brain Injury

Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain

A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients

Gadobutrol Pharmacokinetic and Safety Study in Pediatric Subjects Aged <2 Years (Term Newborn Infants to Toddlers 23 Months of Age Inclusive)

The CDR Implementation Trial

A Phase I-Ib/II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 Alone and in Combination With Bortezomib, With or Without Dexamethasone, in Patients With Relapsed or Refractory Multiple Myeloma.

LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension

Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763

Study to Evaluate the Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic Function

Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose CFZ533 in Rheumatoid Arthritis Patients

Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD

Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis

Using SMART Design to Improve Symptom Management Strategies Among Cancer Patients